<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MT2/CD45RA and anti-bcl-2 protein (Bcl-2) monoclonal antibodies are useful markers in distinguishing follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from reactive <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> of the lymph nodes </plain></SENT>
<SENT sid="1" pm="."><plain>We examined biopsy specimens from 11 patients with primary cutaneous B-cell follicle center <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 10 patients with <z:e sem="disease" ids="C0311220" disease_type="Neoplastic Process" abbrv="">cutaneous pseudolymphomas</z:e> with germinal centers, and 6 patients with inflammatory infiltrates with germinal centers in non-lymphoid <z:e sem="disease" ids="C0037286" disease_type="Neoplastic Process" abbrv="">cutaneous tumors</z:e> (3 <z:hpo ids='HP_0002671'>basal cell carcinomas</z:hpo>, 2 <z:hpo ids='HP_0002861'>malignant melanomas</z:hpo>, and 1 solar <z:e sem="disease" ids="C0022593" disease_type="Disease or Syndrome" abbrv="">keratosis</z:e>), in order to evaluate the utility of MT2 and anti-Bcl-2 antibodies in differentiating benign from malignant germinal center cell proliferations in the skin </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemical evaluation of MT2 and Bcl-2 was focused exclusively on the reactivity of germinal center cells </plain></SENT>
<SENT sid="3" pm="."><plain>Specific membranous MT2 positivity was found in 2/11 cutaneous follicle center <z:hpo ids='HP_0002665'>lymphomas</z:hpo>; a diffuse, non-specific staining pattern was identified in 3/11 follicle center <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and in 1/6 inflammatory infiltrates in non-<z:mp ids='MP_0002022'>lymphoid tumors</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>A negative MT2 reaction was observed in 6/11 follicle center cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, in <z:hpo ids='HP_0000001'>all</z:hpo> cases of <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphomas</z:e> and in 5/6 inflammatory infiltrates in non-<z:mp ids='MP_0002022'>lymphoid tumors</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Bcl-2 positivity was detected only in 1/11 follicle center <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Germinal center cells in <z:hpo ids='HP_0000001'>all</z:hpo> other cases were Bcl-2 negative </plain></SENT>
<SENT sid="7" pm="."><plain>Our results suggest that MT2 and anti-Bcl-2 antibodies are only of limited value in differentiating primary cutaneous follicle center <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from <z:e sem="disease" ids="C0311220" disease_type="Neoplastic Process" abbrv="">cutaneous pseudolymphomas</z:e> with germinal centers </plain></SENT>
</text></document>